Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients

Annals of Surgical Oncology

Volumn 19, Issue 1, 2012, Pages 217-224

  Azab, Basem ^a   Bhatt, Vijaya R ^a   Phookan, Jaya ^a   Murukutla, Srujitha ^a   Kohn, Nina ^b   Terjanian, Terenig ^a   Widmann, Warren D ^a  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; HUMAN; HUMAN CELL; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; NEUTROPHIL TO LYMPHOCYTE RATIO; SURVIVAL PREDICTION;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; LYMPHOCYTES; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84856679198     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1814-0     Document Type: Article

References (31)

1. A Jemal R Siegel E Ward T Murray J Xu C Smigal, et al. 2006 Cancer statistics, 2006 CA Cancer J Clin. 56 106 130 16514137 10.3322/canjclin.56.2.106
2. C Sotiriou SY Neo LM McShane EL Korn PM Long A Jazaeri, et al. 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA. 100 10393 10398 12917485 10.1073/pnas.1732912100 1:CAS:528:DC%2BD3sXntFynsrk%3D
3. LJ van't Veer H Dai MJ van de Vijver YD He AA Hart M Mao, et al. 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature. 415 530 536 10.1038/415530a
4. F Balkwill A Mantovani 2001 Inflammation and cancer: back to Virchow? Lancet. 357 539 545 11229684 10.1016/S0140-6736(00)04046-0 1:CAS:528: DC%2BD3MXhsVKltb0%3D
5. KM Sarraf E Belcher E Raevsky AG Nicholson P Goldstraw E Lim 2009 Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer J Thorac Cardiovasc Surg. 137 425 428 19185164 10.1016/j.jtcvs.2008.05.046
6. Y Kishi S Kopetz YS Chun M Palavecino EK Abdalla JN Vauthey 2009 Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy Ann Surg Oncol. 16 614 622 19130139 10.1245/s10434-008-0267-6
7. T Yamanaka S Matsumoto S Teramukai R Ishiwata Y Nagai M Fukushima 2007 The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer Oncology. 73 215 220 18424885 10.1159/000127412
8. KJ Halazun MA Hardy AA Rana DC Woodland 4th EJ Luyten S Mahadev, et al. 2009 Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma Ann Surg. 250 141 151 19561458 10.1097/SLA.0b013e3181a77e59
9. M Aliustaoglu A Bilici M Seker F Dane M Gocun V Konya, et al. 2010 The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer Hepatogastroenterology. 57 640 645 20698242
10. P Fogar C Sperti D Basso MC Sanzari E Greco C Davoli, et al. 2006 Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome Pancreas. 32 22 28 16340740 10.1097/01.mpa.0000188305.90290.50
11. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al., eds. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag, 2002.
12. H Schmidt L Bastholt P Geertsen IJ Christensen S Larsen J Gehl, et al. 2005 Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model Br J Cancer. 93 273 278 16052222 10.1038/sj.bjc.6602702 1:CAS:528: DC%2BD2MXmvFensLg%3D
13. J Atzpodien P Royston T Wandert M Reitz 2003 Metastatic renal carcinoma comprehensive prognostic system Br J Cancer. 88 348 353 12569375 10.1038/sj.bjc.6600768 1:STN:280:DC%2BD3s7gtlyntA%3D%3D
14. F Donskov KM Bennedsgaard M Hokland N Marcussen R Fisker HH Madsen, et al. 2004 Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma Cancer Immunol Immunother. 53 729 739 15088127 10.1007/s00262-004-0525-9 1:CAS:528:DC%2BD2cXltF2hsrk%3D
15. S Negrier B Escudier F Gomez JY Douillard A Ravaud C Chevreau, et al. 2002 Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunotherapie Ann Oncol. 13 1460 1468 12196373 10.1093/annonc/mdf257 1:STN:280:DC%2BD38vjvVGitA%3D%3D
16. S Teramukai T Kitano Y Kishida M Kawahara K Kubota K Komuta, et al. 2009 Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03 Eur J Cancer. 45 1950 1958 19231158 10.1016/j.ejca.2009.01. 023
17. JE De Larco BR Wuertz LT Furcht 2004 The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8 Clin Cancer Res. 10 4895 4900 15297389 10.1158/1078-0432.CCR-03-0760
18. MM Queen RE Ryan RG Holzer CR Keller-Peck CL Jorcyk 2005 Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression Cancer Res. 65 8896 8904 16204061 10.1158/0008-5472.CAN-05- 1734 1:CAS:528:DC%2BD2MXhtVKiu73P
19. JE Niederhuber 1997 Cancer vaccines: the molecular basis for T cell killing of tumor cells Oncologist. 2 280 283 10388060
20. CG Clemente MC Mihm Jr R Bufalino S Zurrida P Collini N Cascinelli 1996 Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma Cancer. 77 1303 1310 8608507 10.1002/(SICI)1097- 0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5 1:STN:280: DyaK287pslChtA%3D%3D
21. AC Diederichsen JB Hjelmborg PB Christensen J Zeuthen C Fenger 2003 Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells Cancer Immunol Immunother. 52 423 428 12695859 10.1007/s00262-003-0388-5 1:CAS:528: DC%2BD3sXkvFynu7w%3D
22. J Galon A Costes F Sanchez-Cabo A Kirilovsky B Mlecnik C Lagorce-Pagès, et al. 2006 Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science. 313 1960 1964 17008531 10.1126/science.1129139 1:CAS:528:DC%2BD28XhtVSnsrnK
23. Y Naito K Saito K Shiiba A Ohuchi K Saigenji H Nagura, et al. 1998 CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Res. 58 3491 3494 9721846 1:CAS:528:DyaK1cXlsFajsb4%3D
24. F Pages A Berger M Camus F Sanchez-Cabo A Costes R Molidor, et al. 2005 Effector memory T cells, early metastasis, and survival in colorectal cancer N Engl J Med. 353 2654 2666 16371631 10.1056/NEJMoa051424 1:CAS:528: DC%2BD2MXhtlarsrrE
25. F Pages A Kirilovsky B Mlecnik M Asslaber M Tosolini G Bindea, et al. 2009 In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer J Clin Oncol. 27 5944 5951 19858404 10.1200/JCO.2008.19.6147 1:CAS:528:DC%2BC3cXhtVWisL8%3D
26. E Sato SH Olson J Ahn B Bundy H Nishikawa F Qian, et al. 2005 Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci USA. 102 18538 18543 16344461 10.1073/pnas.0509182102 1:CAS:528:DC%2BD28Xpt1Om
27. L Zhang JR Conejo-Garcia D Katsaros PA Gimotty M Massobrio G Regnani, et al. 2003 Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N Engl J Med. 348 203 213 12529460 10.1056/NEJMoa020177 1:CAS:528:DC%2BD3sXksVehug%3D%3D
28. Dallman PR. Blood and blood-forming tissues. In: Rudolph AM, ed. Rudolph's pediatrics. 16th ed. New York: Appleton-Century-Crofts; 1977. p. 1178.
29. Geaghan MS. Appendix. In: Hoffman R, Benz EJ, Shattil SJ, Cohen H, eds. Hematology: Basic Principles and Practice. 4th ed. Philadelphia: Elsevier Churchill Livingstone, 2005. p. 2733.
30. Altman PL, Dittmer DS. Blood and other body fluids. Washington: Federation of American Societies for Experimental Biology, 1961.
31. Daniel RH. Examination of the blood. In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT, eds. Williams hematology. 7th ed. New York: McGraw-Hill, Inc.; 2006. p. 12.